Days At A Glance Speakers Session Type Search
Type

    07:30 - 08:45 
    Registration
    12:30 - 14:30 
    Networking session
    14:50 - 16:20 
    Children's bones in health and disease
    Children's bones in health and disease
    Bone Fraglity
    Helsinki, Finland
    Children's bones in health and disease
    Bone Mineralisation
    Suita, Japan
    Children's bones in health and disease
    Bone Dyspasia
    London, UK
    Children's bones in health and disease
    Abnormality of calcium and phosphate homeostasis
    Paris, France
    16:30 - 17:30 
    Workshop: Osteogenesis imperfecta
    Workshop: Osteogenesis imperfecta
    Introduction
    UK
    Workshop: Osteogenesis imperfecta
    Current approaches to treatment
    Helsinki, Finland
    Workshop: Osteogenesis imperfecta
    What does the future hold
    Ontario , Canada
    17:30 - 17:45 
    Welcome Address
    18:00 - 19:30 
    Satellite symposium: Novel insights into the broad clinical manifestations and management of XLH

    07:30 - 08:45 
    Registration
    08:00 - 08:45 
    Meet the expert
    Meet the expert
    Prevention of rickets and osteomalacia - why, how?
    Linz, Austria
    08:00 - 08:45 
    Meet the expert
    Meet the expert
    Physical activity to improve bone stability
    08:00 - 08:45 
    Meet the expert
    Meet the expert
    Molecular mechanisms of disorders with abnormal bone mass and fragility
    Berlin, Germany
    09:00 - 10:00 
    What is new: 2 years in review
    IS01
    What is new: 2 years in review
    Highlights in basic bone research
    Boston, USA
    IS02
    What is new: 2 years in review
    Highlights in clinical bone research
    Montreal, Canada
    10:30 - 11:00 
    Charles Slemenda Award
    Charles Slemenda Award
    Charles Slemenda Award
    Montreal, Canada
    11:00 - 11:40 
    Oral communications: Genetics
    OC1
    Oral communications: Genetics
    NBAS variants causing a novel form of inherited bone fragility
    Sheffield, UK
    OC2
    Oral communications: Genetics
    Methylation patterns at the novel DMR of GNAS (GNAS-AS2) in pseudohypoparathyroidism 1B (PHP1B or iPPSD3) subtypes
    Paris, France
    OC3
    Oral communications: Genetics
    Principal component-derived bone density phenotypes and genetic regulation of the pediatric skeleton
    Philadelphia, USA
    OC4
    Oral communications: Genetics
    25-hydroxyvitamin D response to antenatal cholecalciferol supplementation is associated with common vitamin D related genetic variants: findings from the MAVIDOS trial
    Southampton, UK
    11:40 - 12:00 
    Poster Pitching
    P013
    Poster Pitching
    Longitudinal evaluation of bone mass, geometry and metabolism in adolescent male athletes. The PRO-BONE study
    Exeter, UK
    P019
    Poster Pitching
    Zebrafish as model organism for craniosynostosis
    Würzburg, Germany
    P027
    Poster Pitching
    Sex and iron modify fibroblast growth factor 23 concentrations in 1-year-old children
    Helsinki, Finland
    P039
    Poster Pitching
    Cystinosin deficiency affects bone phenotype
    Rome, Italy
    P065
    Poster Pitching
    A novel form of congenital rickets due to a recurrent gain of function mutation in CYP3A4 
    Melbourne, Australia
    P079
    Poster Pitching
    Assessment of a semi-automated software program for the identification of vertebral fractures in children
    Lucknow, India
    P125
    Poster Pitching
    Identification and characterization of a novel microRNA inhibiting osteoblast functions by suppressing actin polymerization
    Lucknow, India
    P141
    Poster Pitching
    Unique correlation pattern between cortical trabecular bone qualities and standard dynamometer handgrip strength in girls with adolescent idiopathic scoliosis (AIS)?
    Shatin, Hong Kong
    P161
    Poster Pitching
    Early-life vitamin D status and bone mass at five years in a prospective birth cohort study
    Cork, Ireland
    P189
    Poster Pitching
    A deep phenotyping of autosomal dominant osteopetrosis type 2 (ADO2) mouse model revealed multiorgan dysfunctions
    14:00 - 15:30 
    Basic bone biology: osteoblasts, osteocytes, microstructure
    IS03
    Basic bone biology: osteoblasts, osteocytes, microstructure
    Bone cells in health and disease
    Pavia, Italy
    IS04
    Basic bone biology: osteoblasts, osteocytes, microstructure
    Cortical bone structure and material properties
    Hamburg, Germany
    IS05
    Basic bone biology: osteoblasts, osteocytes, microstructure
    Skeletal mineralization – enzymes and animal models
    La Jolla, USA
    15:30 - 16:30 
    Oral communications: Epidemiology and Nutrition
    OC5
    Oral communications: Epidemiology and Nutrition
    Eight-year longitudinal analysis of physical activity and bone strength during adolescence: the Iowa Bone Development Study
    Iowa City, USA
    OC6
    Oral communications: Epidemiology and Nutrition
    Lean mass accretion increases during summer and positively associates with vitamin D status in healthy children 2-8 years
    Montreal, Canada
    OC7
    Oral communications: Epidemiology and Nutrition
    The effect of antenatal iron supplementation on fibroblast growth factor-23 concentration in mothers and infants: a randomised controlled trial in rural Kenya
    Cambridge, UK
    OC8
    Oral communications: Epidemiology and Nutrition
    Effective therapeutic control of curve progression using calcium and vitamin D supplementation for adolescent idiopathic scoliosis – a randomized double-blinded placebo-controlled trial
    Hong Kong, Hong Kong
    OC9
    Oral communications: Epidemiology and Nutrition
    Calcium carbonate supplementation of pregnant rural Gambian mothers alters offspring IGF-1 at age 7.5 years in a sex-dependent manner
    Cambridge, UK
    OC10
    Oral communications: Epidemiology and Nutrition
    Inadequate vitamin D status adversely affects trabecular bone mineral density in 14-18 year old adolescents
    Guildford, Surrey
    17:00 - 18:00 
    Muscle and bone
    IS06
    Muscle and bone
    The mechanobiology of the growing skeleton
    Montreal, Canada
    IS07
    Muscle and bone
    A role for leptin as a myokine mediating muscle-bone interactions
    Atlanta, USA
    18:15 - 19:45 
    Satellie symposium: Hypophosphatasia in children: strengthening the foundations for managing a complex disease

    07:30 - 08:45 
    Registration
    08:00 - 08:45 
    Meet the expert
    Meet the expert
    The genetic basis of bone disorders- what every clinician needs to know
    Helsinki, Finland
    Meet the expert
    Bone pain: mechanisms and intervention
    Bath, UK
    Meet the expert
    DEXA – how, when and what?
    Birmingham, UK
    09:00 - 10:30 
    Genetics and Epigenetics: The impact for rare bone diseases
    IS08
    Genetics and Epigenetics: The impact for rare bone diseases
    Next generation sequencing and genome editing, game changers in the field of skeletal research
    Berlin, Germany
    IS09
    Genetics and Epigenetics: The impact for rare bone diseases
    Skeletal dysplasias
    London, UK
    IS10
    Genetics and Epigenetics: The impact for rare bone diseases
    Arterial calcification syndromes: causes and treatments
    Münster, Germany
    11:00 - 11:40 
    Oral communications: Muscle and bone mineral density
    OC11
    Oral communications: Muscle and bone mineral density
    The effect of whole body vibration training on bone and muscle function in children with osteogenesis imperfecta and limited mobility: a randomized controlled pilot trial
    Linz, Austria
    OC12
    Oral communications: Muscle and bone mineral density
    Fracture incident rate and growth in a nationwide cohort of boys with Duchenne muscular dystrophy
    Glasgow, UK
    OC13
    Oral communications: Muscle and bone mineral density
    Enterococccus faecium abundance in gut microbiome is associated with higher bone mineral density in school age children
    Rotterdam, Netherlands
    OC14
    Oral communications: Muscle and bone mineral density
    Body composition and associated biomarkers as determinants of bone mineral density in children 6-8 years of age - the Physical Activity and Nutrition in Children (PANIC) study
    Kuopio, Finland
    11:40 - 12:00 
    Poster pitching
    P004
    Poster pitching
    Bone mass tracks into teenage years
    Odense, Denmark
    P030
    Poster pitching
    Outcomes of zoledronic acid use in paediatric conditions
    P034
    Poster pitching
    Identification of bone remodelling alterations in Gorham-Stout disease
    Melbourne, Australia
    P054
    Poster pitching
    The influence of immune dysregulation on bone metabolism in children with inflammatory bowel disease: the potential for bone as a secondary lymphoid organ
    Sheffield, UK
    P080
    Poster pitching
    Bone age assessment using Greulich and Pyle and Tanner-Whitehouse methods: a systematic review
    Sheffield, UK
    P102
    Poster pitching
    Do measures of adiposity and muscle cross-sectionally predict the health of weight-bearing bones in 11-12 year old Australian children? A population-based study
    Melbourne, Australia
    P114
    Poster pitching
    Rare copy number variants in array-based comparative genomic hybridization in early-onset skeletal fragility
    Stockholm, Sweden
    P132
    Poster pitching
    Anti-RANKL treatment in a murine model of fibrous dysplasia
    Rome, Italy
    P142
    Poster pitching
    Walking within 12 months of age is related to higher whole body lean mass and bone mineral density in children at 3 years of age
    Ottawa, Canada
    P182
    Poster pitching
    Osteonecrosis results in significant long term morbidity in patients with acute lymphoblastic leukaemia
    Leeds Teaching Hospital, Leeds, UK
    P202
    Poster pitching
    Osteosarcoma-derived extracellular vesicles induce tumoral-like phenotypes in normal cells
    Rome, Italy
    14:00 - 15:00 
    Rare bone diseases
    IS11
    Rare bone diseases
    Overview: why study rare bone diseases?
    Rotterdam, Netherlands
    IS12
    Rare bone diseases
    The ERNS as a tool for the European research on rare diseases
    Oxford, UK
    15:00 - 15:30 
    Oral communications: Bone fragility and metabolism
    OC15
    Oral communications: Bone fragility and metabolism
    Fractures in school age children in relation to sex, ethnic background and bone mineral density: the Generation R study
    Rotterdam, Netherlands
    OC16
    Oral communications: Bone fragility and metabolism
    Pediatric hypophosphatasia – a retrospective single-center chart review of 50 children
    Würzburg, Germany
    OC17
    Oral communications: Bone fragility and metabolism
    Vertebral fractures in children with chronic inflammatory and/or disabling conditions: the SNAP study
    Birmingham, UK
    16:00 - 17:30 
    Chronic disease and bone
    IS13
    Chronic disease and bone
    Osteoporosis in boys with Duchenne Muscular Dystrophy: morbidity, mechanisms and the path forward
    Ottawa, Canada
    IS14
    Chronic disease and bone
    Bone, body composition and metabolic abnormalities after allogeneic hematopoietic stem cell transplantation during childhood
    Philadelphia, USA
    IS15
    Chronic disease and bone
    An integrated approach to kidney bone disease across the spectrum
    Chicago, USA
    17:30 - 18:30 
    Workshop: Novel perspectives in two rare bone disorders

    07:30 - 08:45 
    Registration
    08:00 - 08:45 
    Meet the expert
    Meet the expert
    Recurrent fractures in childhood – causes, investigations and management
    Sheffield, UK
    Meet the expert
    From bench to bedside: Looking at the use of HR CT and QCT in a diagnostic setting
    Southampton, UK
    Meet the expert
    Managing hypercalcemia in neonates/infants
    Paris, France
    09:00 - 10:00 
    Nutrition and bone health
    IS16
    Nutrition and bone health
    Body composition and physical activity
    South Dakota, USA
    IS17
    Nutrition and bone health
    Factors influencing peak bone mass
    10:10 - 11:00 
    Oral communications: Miscellaneous
    OC18
    Oral communications: Miscellaneous
    Stimulation of angiogenesis and osteogenesis by enhanced preosteoclast platelet derived growth factor type BB attenuates glucocorticoid-induced osteoporosis in growing mice
    Baltimore, USA
    OC19
    Oral communications: Miscellaneous
    Mesenchymal stromal stem cells in pediatric orthopedic oncology, focus on osteosarcoma
    Nantes, France
    OC20
    Oral communications: Miscellaneous
    Autoimmune hyperphosphatemic tumoral calcinosis
    Bethesda, USA
    OC21
    Oral communications: Miscellaneous
    Scoliosis in fibrous dysplasia/McCune-Albright syndrome
    Bethesda, USA
    OC22
    Oral communications: Miscellaneous
    Type I collagen C-propeptide cleavage deficiency increases bone mineralization and alters bone cell differentiation
    Bethesda, USA
    11:30 - 12:30 
    Signalling pathways and their significance for bone health and disease (concurrently with Allied Health Professionals session)
    IS18
    Signalling pathways and their significance for bone health and disease (concurrently with Allied Health Professionals session)
    Phosphate and FGF23 signalling
    Lyons, France
    IS19
    Signalling pathways and their significance for bone health and disease (concurrently with Allied Health Professionals session)
    Signalling pathways and their significance for bone health and disease. PTH/cAMP/PKA
    Paris, France
    IS20
    Signalling pathways and their significance for bone health and disease (concurrently with Allied Health Professionals session)
    Canonical Wnt signaling in bone health and disease
    Antwerp, Belgium
    11:30 - 12:30 
    Allied health professionals session (concurrently with signaling pathways symposium)
    P097
    Allied health professionals session (concurrently with signaling pathways symposium)
    Evaluation of the use of body quantitative computed tomography for the assessment of the tibia in children with neurofibromatosis 1
    Manchester, UK
    P020
    Allied health professionals session (concurrently with signaling pathways symposium)
    Age at onset of walking affects bone mineral content in early childhood
    Helsinki, Finland
    P007
    Allied health professionals session (concurrently with signaling pathways symposium)
    Effects of a 8-month physical activity and nutrition-induced weight loss program on bone health of obese adolescents
    Aubiere, France
    P101
    Allied health professionals session (concurrently with signaling pathways symposium)
    Establishing the clinical need for a dedicated service for children and adolescents with osteogenesis imperfecta in the Republic of Ireland
    Dublin, Ireland
    P204
    Allied health professionals session (concurrently with signaling pathways symposium)
    Is a modified version of the Childhood Health Assessment Questionnaire (CHAQ) a useful tool to identify the level of disability in children with osteogenesis imperfecta?
    Birmingham, UK
    P208
    Allied health professionals session (concurrently with signaling pathways symposium)
    Social barriers and needs of children with osteogenesis imperfecta (OI): a qualitative descriptive interview-based study
    Bialystok, Poland
    13:10 - 14:10 
    Treating children’s bones: present and future
    IS21
    Treating children’s bones: present and future
    BOOSTB4: Boost Brittle Bones Before Birth, A clinical trial on pre- and/or postnatal stemm cell transplantation for treatment of osteogenesis imperfecta
    Huddinge, Sweden
    IS22
    Treating children’s bones: present and future
    Role of microRNAs in the development of osteosarcoma
    Huddinge, Sweden
    14:15 - 15:05 
    Oral communications: Hot topics
    OC23
    Oral communications: Hot topics
    Sustained radiographic and functional improvements with asfotase alfa treatment from up to 7 years in children with hypophosphatasia
    Indianapolis, USA
    OC24
    Oral communications: Hot topics
    KRN23 effects on phosphate and vitamin D dysregulation in children <5 years old with x-linked hypophosphatemia (XLH)
    Indianapolis, USA
    OC25
    Oral communications: Hot topics
    Biochemical and physical function outcomes after 5 years of treatment with asfotase alfa in adolescents and adults with hypophosphatasia: phase 2 study results
    Indianapolis, USA
    OC26
    Oral communications: Hot topics
    A randomized, open-label phase 2 study of KRN23, an investigational fully human anti-FGF23 monoclonal antibody, in children with x-linked hypophosphatemia (XLH)
    Manchester, UK
    LB1
    Oral communications: Hot topics
    Treatment with a novel activin receptor IIB ligand trap improves muscle mass and bone geometry in a mouse model of severe osteogenesis imperfecta
    Montreal, Canada
    15:10 - 15:25 
    Presentation of awards
    15:25 - 15:30 
    Close and final remarks
Fawaz Alqahtani
Lucknow, India
Sun 11 11:49
P079
Poster Pitching
Assessment of a semi-automated software program for the identification of vertebral fractures in children
Lucknow, India
Khalaf Alshamrani
Sheffield, UK
Mon 12 11:46
P080
Poster pitching
Bone age assessment using Greulich and Pyle and Tanner-Whitehouse methods: a systematic review
Sheffield, UK
Nadia Amin
Leeds Teaching Hospital, Leeds, UK
Mon 12 11:53:30
P182
Poster pitching
Osteonecrosis results in significant long term morbidity in patients with acute lymphoblastic leukaemia
Leeds Teaching Hospital, Leeds, UK
Justine Bacchetta
Lyons, France
Tue 13 11:30
IS18
Signalling pathways and their significance for bone health and disease (concurrently with Allied Health Professionals session)
Phosphate and FGF23 signalling
Lyons, France
Meena Balasubramanian
Sheffield, UK
Sun 11 11:00
OC1
Oral communications: Genetics
NBAS variants causing a novel form of inherited bone fragility
Sheffield, UK
Roland Baron
Boston, USA
Sun 11 09:00
IS01
What is new: 2 years in review
Highlights in basic bone research
Boston, USA
Giulia Battafarano
Rome, Italy
Sun 11 11:46
P039
Poster Pitching
Cystinosin deficiency affects bone phenotype
Rome, Italy
Suzanne Bell
Birmingham, UK
Tue 13 11:58
P204
Allied health professionals session (concurrently with signaling pathways symposium)
Is a modified version of the Childhood Health Assessment Questionnaire (CHAQ) a useful tool to identify the level of disability in children with osteogenesis imperfecta?
Birmingham, UK
Nick Bishop
Sheffield, UK
Tue 13
Meet the expert
Recurrent fractures in childhood – causes, investigations and management
Sheffield, UK
Rabea Bleumel
Würzburg, Germany
Sun 11 11:41:30
P019
Poster Pitching
Zebrafish as model organism for craniosynostosis
Würzburg, Germany
Alison Boyce
Bethesda, USA
Tue 13 10:40
OC21
Oral communications: Miscellaneous
Scoliosis in fibrous dysplasia/McCune-Albright syndrome
Bethesda, USA
Vickie Braithwaite
Cambridge, UK
Sun 11 15:50
OC7
Oral communications: Epidemiology and Nutrition
The effect of antenatal iron supplementation on fibroblast growth factor-23 concentration in mothers and infants: a randomised controlled trial in rural Kenya
Cambridge, UK
Neil Brett
Montreal, Canada
Sun 11 15:40
OC6
Oral communications: Epidemiology and Nutrition
Lean mass accretion increases during summer and positively associates with vitamin D status in healthy children 2-8 years
Montreal, Canada
Christine Burren
UK
Sat 10
Workshop: Osteogenesis imperfecta
Introduction
UK
Björn Busse
Hamburg, Germany
Sun 11 14:30
IS04
Basic bone biology: osteoblasts, osteocytes, microstructure
Cortical bone structure and material properties
Hamburg, Germany
Carol Chaomh
Cork, Ireland
Sun 11 11:53:30
P161
Poster Pitching
Early-life vitamin D status and bone mass at five years in a prospective birth cohort study
Cork, Ireland
Elodie Chaplais
Aubiere, France
Tue 13 11:44
P007
Allied health professionals session (concurrently with signaling pathways symposium)
Effects of a 8-month physical activity and nutrition-induced weight loss program on bone health of obese adolescents
Aubiere, France
Ka-Yee Cheuk
Shatin, Hong Kong
Sun 11 11:52
P141
Poster Pitching
Unique correlation pattern between cortical trabecular bone qualities and standard dynamometer handgrip strength in girls with adolescent idiopathic scoliosis (AIS)?
Shatin, Hong Kong
Jacqui Clinch
Bath, UK
Mon 12
Meet the expert
Bone pain: mechanisms and intervention
Bath, UK
Alice Costantini
Stockholm, Sweden
Mon 12 11:49
P114
Poster pitching
Rare copy number variants in array-based comparative genomic hybridization in early-onset skeletal fragility
Stockholm, Sweden
Nicola Crabtree
Birmingham, UK
Mon 12
Meet the expert
DEXA – how, when and what?
Birmingham, UK
Mon 12 15:20
OC17
Oral communications: Bone fragility and metabolism
Vertebral fractures in children with chronic inflammatory and/or disabling conditions: the SNAP study
Birmingham, UK
Janet Crane
Baltimore, USA
Tue 13 10:10
OC18
Oral communications: Miscellaneous
Stimulation of angiogenesis and osteogenesis by enhanced preosteoclast platelet derived growth factor type BB attenuates glucocorticoid-induced osteoporosis in growing mice
Baltimore, USA
Antonella Forlino
Pavia, Italy
Sun 11 14:00
IS03
Basic bone biology: osteoblasts, osteocytes, microstructure
Bone cells in health and disease
Pavia, Italy
Cecilia Götherström
Huddinge, Sweden
Tue 13 13:10
IS21
Treating children’s bones: present and future
BOOSTB4: Boost Brittle Bones Before Birth, A clinical trial on pre- and/or postnatal stemm cell transplantation for treatment of osteogenesis imperfecta
Huddinge, Sweden
Olja Grgic
Rotterdam, Netherlands
Mon 12 15:00
OC15
Oral communications: Bone fragility and metabolism
Fractures in school age children in relation to sex, ethnic background and bone mineral density: the Generation R study
Rotterdam, Netherlands
Mark Hamrick
Atlanta, USA
Sun 11 17:30
IS07
Muscle and bone
A role for leptin as a myokine mediating muscle-bone interactions
Atlanta, USA
Nick Harvey
Tue 13 09:30
IS17
Nutrition and bone health
Factors influencing peak bone mass
Eric Hesse
Huddinge, Sweden
Tue 13 13:40
IS22
Treating children’s bones: present and future
Role of microRNAs in the development of osteosarcoma
Huddinge, Sweden
Wolfgang Högler
Linz, Austria
Sun 11
Meet the expert
Prevention of rickets and osteomalacia - why, how?
Linz, Austria
Mon 12 11:00
OC11
Oral communications: Muscle and bone mineral density
The effect of whole body vibration training on bone and muscle function in children with osteogenesis imperfecta and limited mobility: a randomized controlled pilot trial
Linz, Austria
Elisa Holmlund-Suila
Helsinki, Finland
Sun 11 11:44:30
P027
Poster Pitching
Sex and iron modify fibroblast growth factor 23 concentrations in 1-year-old children
Helsinki, Finland
Wim Hul
Antwerp, Belgium
Tue 13 12:10
IS20
Signalling pathways and their significance for bone health and disease (concurrently with Allied Health Professionals session)
Canonical Wnt signaling in bone health and disease
Antwerp, Belgium
Erik Imel
Indianapolis, USA
Tue 13 14:25
OC24
Oral communications: Hot topics
KRN23 effects on phosphate and vitamin D dysregulation in children <5 years old with x-linked hypophosphatemia (XLH)
Indianapolis, USA
Alex Ireland
Manchester, UK
Tue 13 11:30
P097
Allied health professionals session (concurrently with signaling pathways symposium)
Evaluation of the use of body quantitative computed tomography for the assessment of the tibia in children with neurofibromatosis 1
Manchester, UK
Melita Irving
London, UK
Sat 10
Children's bones in health and disease
Bone Dyspasia
London, UK
Mon 12 09:30
IS09
Genetics and Epigenetics: The impact for rare bone diseases
Skeletal dysplasias
London, UK
Kathleen Janz
Iowa City, USA
Sun 11 15:30
OC5
Oral communications: Epidemiology and Nutrition
Eight-year longitudinal analysis of physical activity and bone strength during adolescence: the Iowa Bone Development Study
Iowa City, USA
Professsor  Kassim	 Javaid
Oxford, UK
Mon 12 14:30
IS12
Rare bone diseases
The ERNS as a tool for the European research on rare diseases
Oxford, UK
Aljaz John
Lucknow, India
Sun 11 11:50:30
P125
Poster Pitching
Identification and characterization of a novel microRNA inhibiting osteoblast functions by suppressing actin polymerization
Lucknow, India
Jerzy Konstantynowicz
Bialystok, Poland
Tue 13 12:05
P208
Allied health professionals session (concurrently with signaling pathways symposium)
Social barriers and needs of children with osteogenesis imperfecta (OI): a qualitative descriptive interview-based study
Bialystok, Poland
Uwe Kornak
Berlin, Germany
Sun 11
Meet the expert
Molecular mechanisms of disorders with abnormal bone mass and fragility
Berlin, Germany
Mon 12 09:00
IS08
Genetics and Epigenetics: The impact for rare bone diseases
Next generation sequencing and genome editing, game changers in the field of skeletal research
Berlin, Germany
Tsz Lam
Hong Kong, Hong Kong
Sun 11 16:00
OC8
Oral communications: Epidemiology and Nutrition
Effective therapeutic control of curve progression using calcium and vitamin D supplementation for adolescent idiopathic scoliosis – a randomized double-blinded placebo-controlled trial
Hong Kong, Hong Kong
Craig Langman
Chicago, USA
Mon 12 17:00
IS15
Chronic disease and bone
An integrated approach to kidney bone disease across the spectrum
Chicago, USA
Hans Leeuwen
Rotterdam, Netherlands
Mon 12 14:00
IS11
Rare bone diseases
Overview: why study rare bone diseases?
Rotterdam, Netherlands
Agnès Linglart, MD, PhD
Paris, France
Sat 10
Children's bones in health and disease
Abnormality of calcium and phosphate homeostasis
Paris, France
Sun 11 11:10
OC2
Oral communications: Genetics
Methylation patterns at the novel DMR of GNAS (GNAS-AS2) in pseudohypoparathyroidism 1B (PHP1B or iPPSD3) subtypes
Paris, France
Tue 13
Meet the expert
Managing hypercalcemia in neonates/infants
Paris, France
Outi Mäkitie
Helsinki, Finland
Sat 10
Children's bones in health and disease
Bone Fraglity
Helsinki, Finland
Sat 10
Workshop: Osteogenesis imperfecta
Current approaches to treatment
Helsinki, Finland
Mon 12
Meet the expert
The genetic basis of bone disorders- what every clinician needs to know
Helsinki, Finland
Joan Marini
Bethesda, USA
Tue 13 10:50
OC22
Oral communications: Miscellaneous
Type I collagen C-propeptide cleavage deficiency increases bone mineralization and alters bone cell differentiation
Bethesda, USA
Antonio Maurizi
Sun 11 11:55
P189
Poster Pitching
A deep phenotyping of autosomal dominant osteopetrosis type 2 (ADO2) mouse model revealed multiorgan dysfunctions
Ciara McDonnell
Dublin, Ireland
Tue 13 11:51
P101
Allied health professionals session (concurrently with signaling pathways symposium)
Establishing the clinical need for a dedicated service for children and adolescents with osteogenesis imperfecta in the Republic of Ireland
Dublin, Ireland
Carolina Medina-Gomez
Rotterdam, Netherlands
Mon 12 11:20
OC13
Oral communications: Muscle and bone mineral density
Enterococccus faecium abundance in gut microbiome is associated with higher bone mineral density in school age children
Rotterdam, Netherlands
José Millán
La Jolla, USA
Sun 11 15:00
IS05
Basic bone biology: osteoblasts, osteocytes, microstructure
Skeletal mineralization – enzymes and animal models
La Jolla, USA
Jonathan Mitchell
Philadelphia, USA
Sun 11 11:20
OC3
Oral communications: Genetics
Principal component-derived bone density phenotypes and genetic regulation of the pediatric skeleton
Philadelphia, USA
Rebecca Moon
Southampton, UK
Sun 11 11:30
OC4
Oral communications: Genetics
25-hydroxyvitamin D response to antenatal cholecalciferol supplementation is associated with common vitamin D related genetic variants: findings from the MAVIDOS trial
Southampton, UK
Scott Moseley
Indianapolis, USA
Tue 13 14:15
OC23
Oral communications: Hot topics
Sustained radiographic and functional improvements with asfotase alfa treatment from up to 7 years in children with hypophosphatasia
Indianapolis, USA
Tue 13 14:35
OC25
Oral communications: Hot topics
Biochemical and physical function outcomes after 5 years of treatment with asfotase alfa in adolescents and adults with hypophosphatasia: phase 2 study results
Indianapolis, USA
Sogol Mostoufi-Moab
Philadelphia, USA
Mon 12 16:30
IS14
Chronic disease and bone
Bone, body composition and metabolic abnormalities after allogeneic hematopoietic stem cell transplantation during childhood
Philadelphia, USA
Keiichi Ozono
Suita, Japan
Sat 10
Children's bones in health and disease
Bone Mineralisation
Suita, Japan
Raja Padidela
Manchester, UK
Tue 13 14:45
OC26
Oral communications: Hot topics
A randomized, open-label phase 2 study of KRN23, an investigational fully human anti-FGF23 monoclonal antibody, in children with x-linked hypophosphatemia (XLH)
Manchester, UK
Biagio Palmisano
Rome, Italy
Mon 12 11:50:30
P132
Poster pitching
Anti-RANKL treatment in a murine model of fibrous dysplasia
Rome, Italy
Garath Penman
Sheffield, UK
Mon 12 11:44:30
P054
Poster pitching
The influence of immune dysregulation on bone metabolism in children with inflammatory bowel disease: the potential for bone as a secondary lymphoid organ
Sheffield, UK
Ann Prentice
Cambridge, UK
Sun 11 16:10
OC9
Oral communications: Epidemiology and Nutrition
Calcium carbonate supplementation of pregnant rural Gambian mothers alters offspring IGF-1 at age 7.5 years in a sex-dependent manner
Cambridge, UK
Mary Ramnitz
Bethesda, USA
Tue 13 10:30
OC20
Oral communications: Miscellaneous
Autoimmune hyperphosphatemic tumoral calcinosis
Bethesda, USA
Frank Rauch
Montreal, Canada
Sun 11 09:30
IS02
What is new: 2 years in review
Highlights in clinical bone research
Montreal, Canada
Sun 11
Charles Slemenda Award
Charles Slemenda Award
Montreal, Canada
Christine Rodda
Melbourne, Australia
Sun 11 11:47:30
P065
Poster Pitching
A novel form of congenital rickets due to a recurrent gain of function mutation in CYP3A4 
Melbourne, Australia
Maria Rønne
Odense, Denmark
Mon 12 11:40
P004
Poster pitching
Bone mass tracks into teenage years
Odense, Denmark
Michela Rossi
Melbourne, Australia
Mon 12 11:43
P034
Poster pitching
Identification of bone remodelling alterations in Gorham-Stout disease
Melbourne, Australia
Dr Dr. Anya Rothenbuhler
Paris, France
Tue 13 11:50
IS19
Signalling pathways and their significance for bone health and disease (concurrently with Allied Health Professionals session)
Signalling pathways and their significance for bone health and disease. PTH/cAMP/PKA
Paris, France
Frank Rutsch
Münster, Germany
Mon 12 10:00
IS10
Genetics and Epigenetics: The impact for rare bone diseases
Arterial calcification syndromes: causes and treatments
Münster, Germany
Peter Simm
Melbourne, Australia
Mon 12 11:47:30
P102
Poster pitching
Do measures of adiposity and muscle cross-sectionally predict the health of weight-bearing bones in 11-12 year old Australian children? A population-based study
Melbourne, Australia
Taryn Smith
Guildford, Surrey
Sun 11 16:20
OC10
Oral communications: Epidemiology and Nutrition
Inadequate vitamin D status adversely affects trabecular bone mineral density in 14-18 year old adolescents
Guildford, Surrey
Sonja Soininen
Kuopio, Finland
Mon 12 11:30
OC14
Oral communications: Muscle and bone mineral density
Body composition and associated biomarkers as determinants of bone mineral density in children 6-8 years of age - the Physical Activity and Nutrition in Children (PANIC) study
Kuopio, Finland
Bonny Specker
South Dakota, USA
Tue 13 09:00
IS16
Nutrition and bone health
Body composition and physical activity
South Dakota, USA
Josephine Tauer
Montreal, Canada
Tue 13 14:55
LB1
Oral communications: Hot topics
Treatment with a novel activin receptor IIB ligand trap improves muscle mass and bone geometry in a mouse model of severe osteogenesis imperfecta
Montreal, Canada
Valérie Trichet
Nantes, France
Tue 13 10:20
OC19
Oral communications: Miscellaneous
Mesenchymal stromal stem cells in pediatric orthopedic oncology, focus on osteosarcoma
Nantes, France
Enrica Urciuoli
Rome, Italy
Mon 12 11:55
P202
Poster pitching
Osteosarcoma-derived extracellular vesicles induce tumoral-like phenotypes in normal cells
Rome, Italy
Sarah Valkama
Helsinki, Finland
Tue 13 11:37
P020
Allied health professionals session (concurrently with signaling pathways symposium)
Age at onset of walking affects bone mineral content in early childhood
Helsinki, Finland
Dimitris Vlachopoulos
Exeter, UK
Sun 11 11:40
P013
Poster Pitching
Longitudinal evaluation of bone mass, geometry and metabolism in adolescent male athletes. The PRO-BONE study
Exeter, UK
Marius Vogt
Würzburg, Germany
Mon 12 15:10
OC16
Oral communications: Bone fragility and metabolism
Pediatric hypophosphatasia – a retrospective single-center chart review of 50 children
Würzburg, Germany
Leanne Ward
Ontario , Canada
Sat 10
Workshop: Osteogenesis imperfecta
What does the future hold
Ontario , Canada
Leanna Ward
Ottawa, Canada
Mon 12 16:00
IS13
Chronic disease and bone
Osteoporosis in boys with Duchenne Muscular Dystrophy: morbidity, mechanisms and the path forward
Ottawa, Canada
Kate Ward
Southampton, UK
Tue 13
Meet the expert
From bench to bedside: Looking at the use of HR CT and QCT in a diagnostic setting
Southampton, UK
Hope Weiler
Ottawa, Canada
Mon 12 11:52
P142
Poster pitching
Walking within 12 months of age is related to higher whole body lean mass and bone mineral density in children at 3 years of age
Ottawa, Canada
Bettina Willie
Montreal, Canada
Sun 11 17:00
IS06
Muscle and bone
The mechanobiology of the growing skeleton
Montreal, Canada
Jarod Wong
Glasgow, UK
Mon 12 11:10
OC12
Oral communications: Muscle and bone mineral density
Fracture incident rate and growth in a nationwide cohort of boys with Duchenne muscular dystrophy
Glasgow, UK
Margaret Zacharin
Mon 12 11:41:30
P030
Poster pitching
Outcomes of zoledronic acid use in paediatric conditions
Workshop 2
Sat 10 16:30
Workshop: Osteogenesis imperfecta
Sat 10
Workshop: Osteogenesis imperfecta
Introduction
UK
Sat 10
Workshop: Osteogenesis imperfecta
Current approaches to treatment
Helsinki, Finland
Sat 10
Workshop: Osteogenesis imperfecta
What does the future hold
Ontario , Canada
Mon 12 17:30
Workshop: Novel perspectives in two rare bone disorders
Oral 6
Sun 11 11:00
Oral communications: Genetics
Sun 11 11:00
OC1
Oral communications: Genetics
NBAS variants causing a novel form of inherited bone fragility
Sheffield, UK
Sun 11 11:10
OC2
Oral communications: Genetics
Methylation patterns at the novel DMR of GNAS (GNAS-AS2) in pseudohypoparathyroidism 1B (PHP1B or iPPSD3) subtypes
Paris, France
Sun 11 11:20
OC3
Oral communications: Genetics
Principal component-derived bone density phenotypes and genetic regulation of the pediatric skeleton
Philadelphia, USA
Sun 11 11:30
OC4
Oral communications: Genetics
25-hydroxyvitamin D response to antenatal cholecalciferol supplementation is associated with common vitamin D related genetic variants: findings from the MAVIDOS trial
Southampton, UK
Sun 11 15:30
Oral communications: Epidemiology and Nutrition
Sun 11 15:30
OC5
Oral communications: Epidemiology and Nutrition
Eight-year longitudinal analysis of physical activity and bone strength during adolescence: the Iowa Bone Development Study
Iowa City, USA
Sun 11 15:40
OC6
Oral communications: Epidemiology and Nutrition
Lean mass accretion increases during summer and positively associates with vitamin D status in healthy children 2-8 years
Montreal, Canada
Sun 11 15:50
OC7
Oral communications: Epidemiology and Nutrition
The effect of antenatal iron supplementation on fibroblast growth factor-23 concentration in mothers and infants: a randomised controlled trial in rural Kenya
Cambridge, UK
Sun 11 16:00
OC8
Oral communications: Epidemiology and Nutrition
Effective therapeutic control of curve progression using calcium and vitamin D supplementation for adolescent idiopathic scoliosis – a randomized double-blinded placebo-controlled trial
Hong Kong, Hong Kong
Sun 11 16:10
OC9
Oral communications: Epidemiology and Nutrition
Calcium carbonate supplementation of pregnant rural Gambian mothers alters offspring IGF-1 at age 7.5 years in a sex-dependent manner
Cambridge, UK
Sun 11 16:20
OC10
Oral communications: Epidemiology and Nutrition
Inadequate vitamin D status adversely affects trabecular bone mineral density in 14-18 year old adolescents
Guildford, Surrey
Mon 12 11:00
Oral communications: Muscle and bone mineral density
Mon 12 11:00
OC11
Oral communications: Muscle and bone mineral density
The effect of whole body vibration training on bone and muscle function in children with osteogenesis imperfecta and limited mobility: a randomized controlled pilot trial
Linz, Austria
Mon 12 11:10
OC12
Oral communications: Muscle and bone mineral density
Fracture incident rate and growth in a nationwide cohort of boys with Duchenne muscular dystrophy
Glasgow, UK
Mon 12 11:20
OC13
Oral communications: Muscle and bone mineral density
Enterococccus faecium abundance in gut microbiome is associated with higher bone mineral density in school age children
Rotterdam, Netherlands
Mon 12 11:30
OC14
Oral communications: Muscle and bone mineral density
Body composition and associated biomarkers as determinants of bone mineral density in children 6-8 years of age - the Physical Activity and Nutrition in Children (PANIC) study
Kuopio, Finland
Mon 12 15:00
Oral communications: Bone fragility and metabolism
Mon 12 15:00
OC15
Oral communications: Bone fragility and metabolism
Fractures in school age children in relation to sex, ethnic background and bone mineral density: the Generation R study
Rotterdam, Netherlands
Mon 12 15:10
OC16
Oral communications: Bone fragility and metabolism
Pediatric hypophosphatasia – a retrospective single-center chart review of 50 children
Würzburg, Germany
Mon 12 15:20
OC17
Oral communications: Bone fragility and metabolism
Vertebral fractures in children with chronic inflammatory and/or disabling conditions: the SNAP study
Birmingham, UK
Tue 13 10:10
Oral communications: Miscellaneous
Tue 13 10:10
OC18
Oral communications: Miscellaneous
Stimulation of angiogenesis and osteogenesis by enhanced preosteoclast platelet derived growth factor type BB attenuates glucocorticoid-induced osteoporosis in growing mice
Baltimore, USA
Tue 13 10:20
OC19
Oral communications: Miscellaneous
Mesenchymal stromal stem cells in pediatric orthopedic oncology, focus on osteosarcoma
Nantes, France
Tue 13 10:30
OC20
Oral communications: Miscellaneous
Autoimmune hyperphosphatemic tumoral calcinosis
Bethesda, USA
Tue 13 10:40
OC21
Oral communications: Miscellaneous
Scoliosis in fibrous dysplasia/McCune-Albright syndrome
Bethesda, USA
Tue 13 10:50
OC22
Oral communications: Miscellaneous
Type I collagen C-propeptide cleavage deficiency increases bone mineralization and alters bone cell differentiation
Bethesda, USA
Tue 13 14:15
Oral communications: Hot topics
Tue 13 14:15
OC23
Oral communications: Hot topics
Sustained radiographic and functional improvements with asfotase alfa treatment from up to 7 years in children with hypophosphatasia
Indianapolis, USA
Tue 13 14:25
OC24
Oral communications: Hot topics
KRN23 effects on phosphate and vitamin D dysregulation in children <5 years old with x-linked hypophosphatemia (XLH)
Indianapolis, USA
Tue 13 14:35
OC25
Oral communications: Hot topics
Biochemical and physical function outcomes after 5 years of treatment with asfotase alfa in adolescents and adults with hypophosphatasia: phase 2 study results
Indianapolis, USA
Tue 13 14:45
OC26
Oral communications: Hot topics
A randomized, open-label phase 2 study of KRN23, an investigational fully human anti-FGF23 monoclonal antibody, in children with x-linked hypophosphatemia (XLH)
Manchester, UK
Tue 13 14:55
LB1
Oral communications: Hot topics
Treatment with a novel activin receptor IIB ligand trap improves muscle mass and bone geometry in a mouse model of severe osteogenesis imperfecta
Montreal, Canada
Expert 3
Sun 11 08:00
Meet the expert
Sun 11
Meet the expert
Prevention of rickets and osteomalacia - why, how?
Linz, Austria
Mon 12 08:00
Meet the expert
Mon 12
Meet the expert
The genetic basis of bone disorders- what every clinician needs to know
Helsinki, Finland
Mon 12
Meet the expert
Bone pain: mechanisms and intervention
Bath, UK
Mon 12
Meet the expert
DEXA – how, when and what?
Birmingham, UK
Tue 13 08:00
Meet the expert
Tue 13
Meet the expert
Recurrent fractures in childhood – causes, investigations and management
Sheffield, UK
Tue 13
Meet the expert
From bench to bedside: Looking at the use of HR CT and QCT in a diagnostic setting
Southampton, UK
Tue 13
Meet the expert
Managing hypercalcemia in neonates/infants
Paris, France
Plenary 0
Catering and Social 2
Sun 11 10:30
Charles Slemenda Award
Sun 11
Charles Slemenda Award
Charles Slemenda Award
Montreal, Canada
Tue 13 15:10
Presentation of awards
Nurse 9
Sun 11 09:00
What is new: 2 years in review
Sun 11 09:00
IS01
What is new: 2 years in review
Highlights in basic bone research
Boston, USA
Sun 11 09:30
IS02
What is new: 2 years in review
Highlights in clinical bone research
Montreal, Canada
Sun 11 14:00
Basic bone biology: osteoblasts, osteocytes, microstructure
Sun 11 14:00
IS03
Basic bone biology: osteoblasts, osteocytes, microstructure
Bone cells in health and disease
Pavia, Italy
Sun 11 14:30
IS04
Basic bone biology: osteoblasts, osteocytes, microstructure
Cortical bone structure and material properties
Hamburg, Germany
Sun 11 15:00
IS05
Basic bone biology: osteoblasts, osteocytes, microstructure
Skeletal mineralization – enzymes and animal models
La Jolla, USA
Sun 11 17:00
Muscle and bone
Sun 11 17:00
IS06
Muscle and bone
The mechanobiology of the growing skeleton
Montreal, Canada
Sun 11 17:30
IS07
Muscle and bone
A role for leptin as a myokine mediating muscle-bone interactions
Atlanta, USA
Mon 12 09:00
Genetics and Epigenetics: The impact for rare bone diseases
Mon 12 09:00
IS08
Genetics and Epigenetics: The impact for rare bone diseases
Next generation sequencing and genome editing, game changers in the field of skeletal research
Berlin, Germany
Mon 12 09:30
IS09
Genetics and Epigenetics: The impact for rare bone diseases
Skeletal dysplasias
London, UK
Mon 12 10:00
IS10
Genetics and Epigenetics: The impact for rare bone diseases
Arterial calcification syndromes: causes and treatments
Münster, Germany
Mon 12 14:00
Rare bone diseases
Mon 12 14:00
IS11
Rare bone diseases
Overview: why study rare bone diseases?
Rotterdam, Netherlands
Mon 12 14:30
IS12
Rare bone diseases
The ERNS as a tool for the European research on rare diseases
Oxford, UK
Mon 12 16:00
Chronic disease and bone
Mon 12 16:00
IS13
Chronic disease and bone
Osteoporosis in boys with Duchenne Muscular Dystrophy: morbidity, mechanisms and the path forward
Ottawa, Canada
Mon 12 16:30
IS14
Chronic disease and bone
Bone, body composition and metabolic abnormalities after allogeneic hematopoietic stem cell transplantation during childhood
Philadelphia, USA
Mon 12 17:00
IS15
Chronic disease and bone
An integrated approach to kidney bone disease across the spectrum
Chicago, USA
Tue 13 09:00
Nutrition and bone health
Tue 13 09:00
IS16
Nutrition and bone health
Body composition and physical activity
South Dakota, USA
Tue 13 09:30
IS17
Nutrition and bone health
Factors influencing peak bone mass
Tue 13 11:30
Signalling pathways and their significance for bone health and disease (concurrently with Allied Health Professionals session)
Tue 13 11:30
IS18
Signalling pathways and their significance for bone health and disease (concurrently with Allied Health Professionals session)
Phosphate and FGF23 signalling
Lyons, France
Tue 13 11:50
IS19
Signalling pathways and their significance for bone health and disease (concurrently with Allied Health Professionals session)
Signalling pathways and their significance for bone health and disease. PTH/cAMP/PKA
Paris, France
Tue 13 12:10
IS20
Signalling pathways and their significance for bone health and disease (concurrently with Allied Health Professionals session)
Canonical Wnt signaling in bone health and disease
Antwerp, Belgium
Tue 13 13:10
Treating children’s bones: present and future
Tue 13 13:10
IS21
Treating children’s bones: present and future
BOOSTB4: Boost Brittle Bones Before Birth, A clinical trial on pre- and/or postnatal stemm cell transplantation for treatment of osteogenesis imperfecta
Huddinge, Sweden
Tue 13 13:40
IS22
Treating children’s bones: present and future
Role of microRNAs in the development of osteosarcoma
Huddinge, Sweden
Other 3
Sun 11 11:40
Poster Pitching
Sun 11 11:40
P013
Poster Pitching
Longitudinal evaluation of bone mass, geometry and metabolism in adolescent male athletes. The PRO-BONE study
Exeter, UK
Sun 11 11:41:30
P019
Poster Pitching
Zebrafish as model organism for craniosynostosis
Würzburg, Germany
Sun 11 11:44:30
P027
Poster Pitching
Sex and iron modify fibroblast growth factor 23 concentrations in 1-year-old children
Helsinki, Finland
Sun 11 11:46
P039
Poster Pitching
Cystinosin deficiency affects bone phenotype
Rome, Italy
Sun 11 11:47:30
P065
Poster Pitching
A novel form of congenital rickets due to a recurrent gain of function mutation in CYP3A4 
Melbourne, Australia
Sun 11 11:49
P079
Poster Pitching
Assessment of a semi-automated software program for the identification of vertebral fractures in children
Lucknow, India
Sun 11 11:50:30
P125
Poster Pitching
Identification and characterization of a novel microRNA inhibiting osteoblast functions by suppressing actin polymerization
Lucknow, India
Sun 11 11:52
P141
Poster Pitching
Unique correlation pattern between cortical trabecular bone qualities and standard dynamometer handgrip strength in girls with adolescent idiopathic scoliosis (AIS)?
Shatin, Hong Kong
Sun 11 11:53:30
P161
Poster Pitching
Early-life vitamin D status and bone mass at five years in a prospective birth cohort study
Cork, Ireland
Sun 11 11:55
P189
Poster Pitching
A deep phenotyping of autosomal dominant osteopetrosis type 2 (ADO2) mouse model revealed multiorgan dysfunctions
Mon 12 11:40
Poster pitching
Mon 12 11:40
P004
Poster pitching
Bone mass tracks into teenage years
Odense, Denmark
Mon 12 11:41:30
P030
Poster pitching
Outcomes of zoledronic acid use in paediatric conditions
Mon 12 11:43
P034
Poster pitching
Identification of bone remodelling alterations in Gorham-Stout disease
Melbourne, Australia
Mon 12 11:44:30
P054
Poster pitching
The influence of immune dysregulation on bone metabolism in children with inflammatory bowel disease: the potential for bone as a secondary lymphoid organ
Sheffield, UK
Mon 12 11:46
P080
Poster pitching
Bone age assessment using Greulich and Pyle and Tanner-Whitehouse methods: a systematic review
Sheffield, UK
Mon 12 11:47:30
P102
Poster pitching
Do measures of adiposity and muscle cross-sectionally predict the health of weight-bearing bones in 11-12 year old Australian children? A population-based study
Melbourne, Australia
Mon 12 11:49
P114
Poster pitching
Rare copy number variants in array-based comparative genomic hybridization in early-onset skeletal fragility
Stockholm, Sweden
Mon 12 11:50:30
P132
Poster pitching
Anti-RANKL treatment in a murine model of fibrous dysplasia
Rome, Italy
Mon 12 11:52
P142
Poster pitching
Walking within 12 months of age is related to higher whole body lean mass and bone mineral density in children at 3 years of age
Ottawa, Canada
Mon 12 11:53:30
P182
Poster pitching
Osteonecrosis results in significant long term morbidity in patients with acute lymphoblastic leukaemia
Leeds Teaching Hospital, Leeds, UK
Mon 12 11:55
P202
Poster pitching
Osteosarcoma-derived extracellular vesicles induce tumoral-like phenotypes in normal cells
Rome, Italy
Tue 13 11:30
Allied health professionals session (concurrently with signaling pathways symposium)
Tue 13 11:30
P097
Allied health professionals session (concurrently with signaling pathways symposium)
Evaluation of the use of body quantitative computed tomography for the assessment of the tibia in children with neurofibromatosis 1
Manchester, UK
Tue 13 11:37
P020
Allied health professionals session (concurrently with signaling pathways symposium)
Age at onset of walking affects bone mineral content in early childhood
Helsinki, Finland
Tue 13 11:44
P007
Allied health professionals session (concurrently with signaling pathways symposium)
Effects of a 8-month physical activity and nutrition-induced weight loss program on bone health of obese adolescents
Aubiere, France
Tue 13 11:51
P101
Allied health professionals session (concurrently with signaling pathways symposium)
Establishing the clinical need for a dedicated service for children and adolescents with osteogenesis imperfecta in the Republic of Ireland
Dublin, Ireland
Tue 13 11:58
P204
Allied health professionals session (concurrently with signaling pathways symposium)
Is a modified version of the Childhood Health Assessment Questionnaire (CHAQ) a useful tool to identify the level of disability in children with osteogenesis imperfecta?
Birmingham, UK
Tue 13 12:05
P208
Allied health professionals session (concurrently with signaling pathways symposium)
Social barriers and needs of children with osteogenesis imperfecta (OI): a qualitative descriptive interview-based study
Bialystok, Poland
Symposium 3
Sat 10 14:50
Children's bones in health and disease
Sat 10
Children's bones in health and disease
Bone Fraglity
Helsinki, Finland
Sat 10
Children's bones in health and disease
Bone Mineralisation
Suita, Japan
Sat 10
Children's bones in health and disease
Bone Dyspasia
London, UK
Sat 10
Children's bones in health and disease
Abnormality of calcium and phosphate homeostasis
Paris, France
Sat 10 18:00
Satellite symposium: Novel insights into the broad clinical manifestations and management of XLH
Sun 11 18:15
Satellie symposium: Hypophosphatasia in children: strengthening the foundations for managing a complex disease
No Session Type 9
Sat 10 07:30
Registration
Sat 10 12:30
Networking session
Sat 10 17:30
Welcome Address
Sun 11 07:30
Registration
Sun 11 08:00
Meet the expert
Sun 11
Meet the expert
Physical activity to improve bone stability
Sun 11 08:00
Meet the expert
Sun 11
Meet the expert
Molecular mechanisms of disorders with abnormal bone mass and fragility
Berlin, Germany
Mon 12 07:30
Registration
Tue 13 07:30
Registration
Tue 13 15:25
Close and final remarks

0 result(s) found.

Please wait...

     
      - 
     
     
     


    Abstracts from this event
      Abstracts from other events


          Session starts at:
          Abstract time:
        Event:


        Read full abstract